Novo Nordisk
Greg Zahrebelnyy is a seasoned professional with extensive experience in global ethics, risk, and compliance. Currently serving as Senior Director and Head of Global Ethics, Risk and Compliance at LEO Pharma since June 2021, Greg leads a diverse team focused on business ethics, anti-corruption, and enterprise risk management. Prior roles include Head of Third-Party Compliance Management at A.P. Moller - Maersk, Manager in Risk Advisory at Deloitte Danmark, and Senior Risk Advisor at Novo Nordisk. Greg holds a Master of Science in International Business Economics from Aalborg University and a Bachelor of Arts in Business Administration and Management from LCC International University.
This person is not in any teams
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.